Literature DB >> 15855021

Comparative immunogenicity of the hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts.

Wolfgang Jechlinger1, Christoph Haller, Stephanie Resch, Andrea Hofmann, Michael P Szostak, Werner Lubitz.   

Abstract

Two membrane compartments of Escherichia coli ghosts, representing empty bacterial cell envelopes, were investigated as carriers of foreign antigens. By subcutaneous immunisation of mice the immunogenicity of bacterial ghosts carrying the Hepatitis B virus core 149 protein (HBcAg-149) as model antigen anchored either in the inner or the outer membrane of E. coli was compared. Both systems induced significant immune responses against the foreign target antigen, the HBcAg-149, in mice. Results indicate that bacterial ghosts provide an excellent carrier system for antigen delivery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855021     DOI: 10.1016/j.vaccine.2004.11.078

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  18 in total

1.  Autotransporter-based antigen display in bacterial ghosts.

Authors:  Anna Hjelm; Bill Söderström; David Vikström; Wouter S P Jong; Joen Luirink; Jan-Willem de Gier
Journal:  Appl Environ Microbiol       Date:  2014-11-14       Impact factor: 4.792

2.  Characterization of a novel inactivated Salmonella enterica serovar Enteritidis vaccine candidate generated using a modified cI857/λ PR/gene E expression system.

Authors:  Chetan V Jawale; Atul A Chaudhari; Byung Woo Jeon; Rahul M Nandre; John Hwa Lee
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

Review 3.  Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: Set the bugs to work?

Authors:  Fatemeh Farjadian; Mohsen Moghoofei; Soroush Mirkiani; Amir Ghasemi; Navid Rabiee; Shima Hadifar; Ali Beyzavi; Mahdi Karimi; Michael R Hamblin
Journal:  Biotechnol Adv       Date:  2018-02-28       Impact factor: 14.227

Review 4.  Decorating and loading ghosts with allergens for allergen immunotherapy.

Authors:  Songwe Fanuel; Saeideh Tabesh; Huda Fatima Rajani; Sahel Heidari; Esmaeil Sadroddiny; Gholam Ali Kardar
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

5.  Functional display of ice nucleation protein InaZ on the surface of bacterial ghosts.

Authors:  Johannes Kassmannhuber; Mascha Rauscher; Lea Schöner; Angela Witte; Werner Lubitz
Journal:  Bioengineered       Date:  2017-01-25       Impact factor: 3.269

6.  A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.

Authors:  Eno E Ekong; Daniel N Okenu; Jayanti Mania-Pramanik; Qing He; Joseph U Igietseme; Godwin A Ananaba; Deborah Lyn; Carolyn Black; Francis O Eko
Journal:  FEMS Immunol Med Microbiol       Date:  2008-11-18

7.  Construction of a Salmonella Gallinarum ghost as a novel inactivated vaccine candidate and its protective efficacy against fowl typhoid in chickens.

Authors:  Atul A Chaudhari; Chetan V Jawale; Sam Woong Kim; John Hwa Lee
Journal:  Vet Res       Date:  2012-05-23       Impact factor: 3.683

Review 8.  Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?

Authors:  Sharan Bobbala; Sarah Hook
Journal:  Pharm Res       Date:  2016-07-05       Impact factor: 4.580

9.  Enhancement of bacteriolysis of shuffled phage PhiX174 gene E.

Authors:  Shen-ye Yu; Wei Peng; Wei Si; Lu Yin; Si-guo Liu; Hui-fang Liu; Hai-ling Zhao; Chun-lai Wang; Yue-hong Chang; Yue-zhi Lin
Journal:  Virol J       Date:  2011-05-06       Impact factor: 4.099

10.  Vibrio cholerae ghosts (VCG) exert immunomodulatory effect on dendritic cells for enhanced antigen presentation and induction of protective immunity.

Authors:  Francis O Eko; Jayanti Mania-Pramanik; Roshan Pais; Qing Pan; Daniel M N Okenu; Arieian Johnson; Chris Ibegbu; Cheng He; Qing He; Raedeen Russell; Carolyn M Black; Joseph U Igietseme
Journal:  BMC Immunol       Date:  2014-12-31       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.